Search PubMedSearch

PubMed · 7667613

Result, error and uncertainty.

Abstract

Several recent documents, from international standardization bodies, present the philosophical and statistical background for understanding the components of a measured value and its uncertainty, as well as the relevant nomenclature for their description. The value is the output of a function relating values from reading, calibrator, corrections and influence quantities. The corrected value may be regarded as the sum of a true value, bias of measurement procedure, laboratory deviation, and random error; in some cases there are also biases from aberrant sample and undetected mistakes. The contributions of laboratory deviation and random error vary with the precision conditions that must be specified. The uncertainty measures are no longer a sum of systematic errors and the positive square root of quadratically added random errors. Now, the measured corrected value is the best estimate and the components of its uncertainty, one from each input, are all expressed as statistically or non-statistically derived variances that are combined according to the function relating the input values. The positive square root of the outcome is the combined standard uncertainty that is regarded as a standard deviation from which an expanded uncertainty may be obtained by multiplying with a coverage factor.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Dybkaer. 1995. Result, error and uncertainty.. https://doi.org/10.3109/00365519509089602

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

OBJECTIVE: To determine the effectiveness of follow-up tests for signaling recurrences in patients with intermediate- and high-risk malignant melanomas treated with curative intention. DESIGN: Retrospective analysis of prospectively collected data. SETTING: North Central Cancer Treatment Group. PATIENTS: A total of 261 patients with resected local (> or = 1.69 mm) and regional nodal malignant melanomas who were enrolled in a single prospective adjuvant trial were studied. All patients were scheduled to be followed up monthly for 2 months, then every 2 months for the first year, every 4 months the second year, every 6 months the next 3 years, and annually thereafter, with each visit consisting of a history, physical examination, complete blood cell count, blood chemistry panel, and a chest x-ray. RESULTS: Of the 145 evaluable patients who developed recurrent melanomas, 99 patients (68%) developed symptoms that signaled the diagnosis of recurrent disease. Physical examination of asymptomatic patients led to the diagnosis of recurrent disease in 37 patients (26%). The other nine patients (6%) with recurrent disease had abnormal chest x-rays. Laboratory results were never a sole indicator of recurrent disease. CONCLUSION: The majority of recurrences following resection of primary melanomas are discovered by history and/or physical examination despite the frequent use of other follow-up tests. The present data indicate that routine blood analyses and chest x-rays have limited value in the postoperative follow-up of patients with resected intermediate- and high-risk melanomas.

Clinical Laboratory Techniques